Assessment of Colonic Epithelial Integrity With Mucosal Impedance

Completed

Conditions studied: Inflammatory Bowel Diseases

In brief

In this study, the investigators propose to use mucosal impedance (MI), a minimally invasive technology, to detect mucosal damage (i.e. barrier dysfunction) based on mucosal conductivity changes in the colonic epithelium.

Key facts

Study ID

NCT03165058

Run by

Vanderbilt University Medical Center

People needed

32

Starts

2016-11-01

Expected to finish

2019-05-01

Last updated by the study team

2021-05-07

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women over the age of 18 with a diagnosis of IBD (Ulcerative Colitis or Crohn's Disease)
• Men and women undergoing screening colonoscopy (typical age would be 50 or greater but there are exceptions)

You may not qualify if…

• Age less than 18 years old
• Patients unable to give informed consent
• Patients with history of colonic surgeries
• Patients with history of colonic motility disorder

Where it is running

• Vanderbilt University Medical Center Endoscopy Laboratory — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.